Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Coronary Chronic Total Occlusion Revascularization: When, Who and How?
Ricottini E, Coletti F, Nusca A, Cocco N, Corlianò A, Appetecchia A, Melfi R, Mangiacapra F, Gallo P, Rinaldi R, Grigioni F, Ussia GP. Ricottini E, et al. J Clin Med. 2024 Mar 27;13(7):1943. doi: 10.3390/jcm13071943. J Clin Med. 2024. PMID: 38610708 Free PMC article. Review.
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg?
Celeski M, Nusca A, De Luca VM, Antonelli G, Cammalleri V, Melfi R, Mangiacapra F, Ricottini E, Gallo P, Cocco N, Rinaldi R, Grigioni F, Ussia GP. Celeski M, et al. Among authors: ricottini e. J Cardiovasc Dev Dis. 2024 Jan 26;11(2):39. doi: 10.3390/jcdd11020039. J Cardiovasc Dev Dis. 2024. PMID: 38392253 Free PMC article. Review.
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease.
Bernardini F, Nusca A, Coletti F, La Porta Y, Piscione M, Vespasiano F, Mangiacapra F, Ricottini E, Melfi R, Cavallari I, Ussia GP, Grigioni F. Bernardini F, et al. Among authors: ricottini e. Pharmaceutics. 2023 Jul 1;15(7):1858. doi: 10.3390/pharmaceutics15071858. Pharmaceutics. 2023. PMID: 37514043 Free PMC article. Review.
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention.
Paolucci L, Mangiacapra F, Viscusi MM, Ungaro S, Cocchia F, Piccirillo F, Nusca A, Melfi R, Ricottini E, Gallo P, Cocco N, Rinaldi R, Ussia GP, Grigioni F. Paolucci L, et al. Among authors: ricottini e. Cardiovasc Revasc Med. 2023 Mar;48:15-20. doi: 10.1016/j.carrev.2022.10.006. Epub 2022 Oct 19. Cardiovasc Revasc Med. 2023. PMID: 36302704
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data.
Nusca A, Piccirillo F, Bernardini F, De Filippis A, Coletti F, Mangiacapra F, Ricottini E, Melfi R, Gallo P, Cammalleri V, Napoli N, Ussia GP, Grigioni F. Nusca A, et al. Among authors: ricottini e. Int J Mol Sci. 2022 Jun 30;23(13):7261. doi: 10.3390/ijms23137261. Int J Mol Sci. 2022. PMID: 35806265 Free PMC article. Review.
55 results